Daxor (DXR) vs Milestone Scientific (MLSS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Daxor (DXR) has outperformed Milestone Scientific (MLSS) over the past year, losing 18.2% versus a loss of 35.2%. Over five years, DXR leads with a -7.5% price change compared with -82.9% for MLSS. Daxor is the larger company by market cap ($60.8 million vs $31.7 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | MLSS |
|---|---|---|
| Share price | $10.41 | $0.35 |
| Market cap | $60.78M | $31.71M |
| 1-day change | -0.48% | -2.78% |
| YTD return | -29.42% | +29.63% |
| 1-year return | -18.22% | -35.19% |
| 5-year return | -7.47% | -82.94% |
| P/E ratio (TTM) | 9.46 | — |
| EPS (TTM) | $1.10 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.76 | $0.58 |
| 52-week low | $8.56 | $0.22 |
| Distance from 52-week high | -29.47% | -39.66% |
| Analyst consensus | none | none |
| Avg. price target upside | +92.12% | +257.14% |
| Average volume | 17.27K | 128.06K |
| Shares outstanding | 5.84M | 90.61M |
| Employees | — | 15 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DXR has outperformed MLSS by 17.0 percentage points over the past year.
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About Milestone Scientific
MLSS stock →Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.
Health Care · Industrial Specialties · 15 employees
DXR vs MLSS FAQ
Which is bigger, Daxor or Milestone Scientific?
Daxor (DXR) is larger, with a market capitalization of $60.78M compared with $31.71M for Milestone Scientific (MLSS).
Which stock has performed better over the past year, DXR or MLSS?
DXR returned -18.22% over the past 12 months, compared with -35.19% for MLSS (price return, excluding dividends). Past performance does not predict future results.
Are Daxor and Milestone Scientific in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Daxor and Industrial Specialties for Milestone Scientific.